Health Care • Medical/Dental Instruments
$9.00 ▲ +0.39
(+4.57%)
MKT CAP: $21.9M • VOL: 8.3K
52W L $3 52W H $18
ROARABLE / RQD
D- • 42/100
PIOTROSKI
1 / 9
PLRZ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$6.2M | -$1.3M | -$635.0K |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$3.3M | -$1.5M | -$600.0K |
| EBITDA (Normalized) | -$6.2M | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.5M | -$1.1M | -$537.0K |
| Capital Expenditures (CapEx) | $7.0K | — | — |
| Free Cash Flow (FCF) | -$4.5M | -$1.1M | -$537.0K |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -25.1% | -37.6% | — |
| Cash & Short-Term Equivalents | $1.3M | $2.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $21.0M | $5.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PLRZ.